Style | Citing Format |
---|---|
MLA | Shirvani M, et al.. "The Diagnostic Value of Neutrophil to Lymphocyte Ratio As an Effective Biomarker for Eye Disorders: A Meta-Analysis." BioMed Research International, vol. 2022, no. , 2022, pp. -. |
APA | Shirvani M, Soufi F, Nouralishahi A, Vakili K, Salimi A, Luckewold B, Mousavi F, Mohammadzadehsaliani S, Khanzadeh S (2022). The Diagnostic Value of Neutrophil to Lymphocyte Ratio As an Effective Biomarker for Eye Disorders: A Meta-Analysis. BioMed Research International, 2022(), -. |
Chicago | Shirvani M, Soufi F, Nouralishahi A, Vakili K, Salimi A, Luckewold B, Mousavi F, Mohammadzadehsaliani S, Khanzadeh S. "The Diagnostic Value of Neutrophil to Lymphocyte Ratio As an Effective Biomarker for Eye Disorders: A Meta-Analysis." BioMed Research International 2022, no. (2022): -. |
Harvard | Shirvani M et al. (2022) 'The Diagnostic Value of Neutrophil to Lymphocyte Ratio As an Effective Biomarker for Eye Disorders: A Meta-Analysis', BioMed Research International, 2022(), pp. -. |
Vancouver | Shirvani M, Soufi F, Nouralishahi A, Vakili K, Salimi A, Luckewold B, et al.. The Diagnostic Value of Neutrophil to Lymphocyte Ratio As an Effective Biomarker for Eye Disorders: A Meta-Analysis. BioMed Research International. 2022;2022():-. |
BibTex | @article{ author = {Shirvani M and Soufi F and Nouralishahi A and Vakili K and Salimi A and Luckewold B and Mousavi F and Mohammadzadehsaliani S and Khanzadeh S}, title = {The Diagnostic Value of Neutrophil to Lymphocyte Ratio As an Effective Biomarker for Eye Disorders: A Meta-Analysis}, journal = {BioMed Research International}, volume = {2022}, number = {}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Shirvani M AU - Soufi F AU - Nouralishahi A AU - Vakili K AU - Salimi A AU - Luckewold B AU - Mousavi F AU - Mohammadzadehsaliani S AU - Khanzadeh S TI - The Diagnostic Value of Neutrophil to Lymphocyte Ratio As an Effective Biomarker for Eye Disorders: A Meta-Analysis JO - BioMed Research International VL - 2022 IS - SP - EP - PY - 2022 ER - |